APO Research
Talk to an analyst

APO RESEARCH · REPORT

Amino Acid Metabolism Disorder Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Amino Acid Metabolism Disorder Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025191 pages

Choose your research edition.

Industry ResearchAmino Acid Metabolism Disorder Drug Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Amino Acid Metabolism Disorder Drug Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Amino Acid Metabolism Disorder Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amino Acid Metabolism Disorder Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Amino Acid Metabolism Disorder Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Amino Acid Metabolism Disorder Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Amino Acid Metabolism Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Amino Acid Metabolism Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amino Acid Metabolism Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Amino Acid Metabolism Disorder Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Amino Acid Metabolism Disorder Drug include AMINO, BioMarin, DSM, Kyowa Hakko Kirin, Recordati, Shine Star (Hubei) Biological Engineering, Swedish Orphan Biovitrum, GlaxoSmithKline and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Amino Acid Metabolism Disorder Drug market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Amino Acid Metabolism Disorder Drug and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Amino Acid Metabolism Disorder Drug revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Amino Acid Metabolism Disorder Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Amino Acid Metabolism Disorder Drug Segment by Company

AMINO

BioMarin

DSM

Kyowa Hakko Kirin

Recordati

Shine Star (Hubei) Biological Engineering

Swedish Orphan Biovitrum

GlaxoSmithKline

Pfizer

Merck

Sanofi

Amino Acid Metabolism Disorder Drug Segment by Type

Folic Acid

Sapropterin Dihydrochloride

Vitamin D

Vitamin B6 & B12

Betaine

Thiamine

Carglumic Acid

Arginine

Others

Amino Acid Metabolism Disorder Drug Segment by Application

Argininosuccinic Acidemia

Citrullinemia

Homocystinuria

Maple Syrup Urine Disease

Phenylketonuria

Amino Acid Metabolism Disorder Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amino Acid Metabolism Disorder Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amino Acid Metabolism Disorder Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amino Acid Metabolism Disorder Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Amino Acid Metabolism Disorder Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Amino Acid Metabolism Disorder Drug industry.

Chapter 3: Detailed analysis of Amino Acid Metabolism Disorder Drug companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Amino Acid Metabolism Disorder Drugrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Folic Acid Table 3. Key Players of Sapropterin Dihydrochloride Table 4. Key Players of Vitamin D Table 3. Key Players of Vitamin B6 & B12 Table 4. Key Players of Betaine Table 5. Key Players of Thiamine Table 6. Key Players of Carglumic Acid Table 7. Key Players of Arginine Table 8. Key Players of Others Table 9. Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 10. Key Players of Argininosuccinic Acidemia Table 11. Key Players of Citrullinemia Table 12. Key Players of Homocystinuria Table 13. Key Players of Maple Syrup Urine Disease Table 14. Key Players of Phenylketonuria Table 15. Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Amino Acid Metabolism Disorder Drug Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Amino Acid Metabolism Disorder Drug Market Share by Region (2021-2026) Table 18. Global Amino Acid Metabolism Disorder Drug Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Amino Acid Metabolism Disorder Drug Market Share by Region (2027-2032) Table 20. Amino Acid Metabolism Disorder Drug Industry Trends Table 21. Amino Acid Metabolism Disorder Drug Industry Drivers Table 22. Amino Acid Metabolism Disorder Drug Industry Opportunities and Challenges Table 23. Amino Acid Metabolism Disorder Drug Industry Restraints Table 24. Global Amino Acid Metabolism Disorder Drug Revenue by Company (US$ Million) & (2021-2026) Table 25. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Company (2021-2026) Table 26. Global Amino Acid Metabolism Disorder Drug Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 27. Global Amino Acid Metabolism Disorder Drug Key Company Head Office and Area Served Table 28. Global Amino Acid Metabolism Disorder Drug Company, Product Type & Application Table 29. Global Amino Acid Metabolism Disorder Drug Company Establishment Date Table 30. Global Company Market Concentration Ratio (CR5 and HHI) Table 31. Global Amino Acid Metabolism Disorder Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 32. Global Amino Acid Metabolism Disorder Drug Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Amino Acid Metabolism Disorder Drug Market Size by Type (2021-2026) & (US$ Million) Table 34. Global Amino Acid Metabolism Disorder Drug Market Size by Type (2027-2032) & (US$ Million) Table 35. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2021-2026) Table 36. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2027-2032) Table 37. Global Amino Acid Metabolism Disorder Drug Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Amino Acid Metabolism Disorder Drug Market Size by Application (2021-2026) & (US$ Million) Table 39. Global Amino Acid Metabolism Disorder Drug Market Size by Application (2027-2032) & (US$ Million) Table 40. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2021-2026) Table 41. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2027-2032) Table 42. AMINO Company Information Table 43. AMINO Business Overview Table 44. AMINO Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. AMINO Amino Acid Metabolism Disorder Drug Product Portfolio Table 46. AMINO Recent Development Table 47. BioMarin Company Information Table 48. BioMarin Business Overview Table 49. BioMarin Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. BioMarin Amino Acid Metabolism Disorder Drug Product Portfolio Table 51. BioMarin Recent Development Table 52. DSM Company Information Table 53. DSM Business Overview Table 54. DSM Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. DSM Amino Acid Metabolism Disorder Drug Product Portfolio Table 56. DSM Recent Development Table 57. Kyowa Hakko Kirin Company Information Table 58. Kyowa Hakko Kirin Business Overview Table 59. Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Product Portfolio Table 61. Kyowa Hakko Kirin Recent Development Table 62. Recordati Company Information Table 63. Recordati Business Overview Table 64. Recordati Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Recordati Amino Acid Metabolism Disorder Drug Product Portfolio Table 66. Recordati Recent Development Table 67. Shine Star (Hubei) Biological Engineering Company Information Table 68. Shine Star (Hubei) Biological Engineering Business Overview Table 69. Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Product Portfolio Table 71. Shine Star (Hubei) Biological Engineering Recent Development Table 72. Swedish Orphan Biovitrum Company Information Table 73. Swedish Orphan Biovitrum Business Overview Table 74. Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Product Portfolio Table 76. Swedish Orphan Biovitrum Recent Development Table 77. GlaxoSmithKline Company Information Table 78. GlaxoSmithKline Business Overview Table 79. GlaxoSmithKline Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. GlaxoSmithKline Amino Acid Metabolism Disorder Drug Product Portfolio Table 81. GlaxoSmithKline Recent Development Table 82. Pfizer Company Information Table 83. Pfizer Business Overview Table 84. Pfizer Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Pfizer Amino Acid Metabolism Disorder Drug Product Portfolio Table 86. Pfizer Recent Development Table 87. Merck Company Information Table 88. Merck Business Overview Table 89. Merck Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 90. Merck Amino Acid Metabolism Disorder Drug Product Portfolio Table 91. Merck Recent Development Table 92. Sanofi Company Information Table 93. Sanofi Business Overview Table 94. Sanofi Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 95. Sanofi Amino Acid Metabolism Disorder Drug Product Portfolio Table 96. Sanofi Recent Development Table 97. North America Amino Acid Metabolism Disorder Drug Market Size by Type (2021-2026) & (US$ Million) Table 98. North America Amino Acid Metabolism Disorder Drug Market Size by Type (2027-2032) & (US$ Million) Table 99. North America Amino Acid Metabolism Disorder Drug Market Size by Application (2021-2026) & (US$ Million) Table 100. North America Amino Acid Metabolism Disorder Drug Market Size by Application (2027-2032) & (US$ Million) Table 101. North America Amino Acid Metabolism Disorder Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. North America Amino Acid Metabolism Disorder Drug Market Size by Country (2021-2026) Table 103. North America Amino Acid Metabolism Disorder Drug Market Size by Country (2027-2032) Table 104. Europe Amino Acid Metabolism Disorder Drug Market Size by Type (2021-2026) & (US$ Million) Table 105. Europe Amino Acid Metabolism Disorder Drug Market Size by Type (2027-2032) & (US$ Million) Table 106. Europe Amino Acid Metabolism Disorder Drug Market Size by Application (2021-2026) & (US$ Million) Table 107. Europe Amino Acid Metabolism Disorder Drug Market Size by Application (2027-2032) & (US$ Million) Table 108. Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2021-2026) Table 110. Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2027-2032) Table 111. China Amino Acid Metabolism Disorder Drug Market Size by Type (2021-2026) & (US$ Million) Table 112. China Amino Acid Metabolism Disorder Drug Market Size by Type (2027-2032) & (US$ Million) Table 113. China Amino Acid Metabolism Disorder Drug Market Size by Application (2021-2026) & (US$ Million) Table 114. China Amino Acid Metabolism Disorder Drug Market Size by Application (2027-2032) & (US$ Million) Table 115. Asia Amino Acid Metabolism Disorder Drug Market Size by Type (2021-2026) & (US$ Million) Table 116. Asia Amino Acid Metabolism Disorder Drug Market Size by Type (2027-2032) & (US$ Million) Table 117. Asia Amino Acid Metabolism Disorder Drug Market Size by Application (2021-2026) & (US$ Million) Table 118. Asia Amino Acid Metabolism Disorder Drug Market Size by Application (2027-2032) & (US$ Million) Table 119. Asia Amino Acid Metabolism Disorder Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Asia Amino Acid Metabolism Disorder Drug Market Size by Country (2021-2026) Table 121. Asia Amino Acid Metabolism Disorder Drug Market Size by Country (2027-2032) Table 122. South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Type (2021-2026) & (US$ Million) Table 123. South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Type (2027-2032) & (US$ Million) Table 124. South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Application (2021-2026) & (US$ Million) Table 125. South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Application (2027-2032) & (US$ Million) Table 126. South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2021-2026) Table 128. South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2027-2032) Table 129. Research Programs/Design for This Report Table 130. Authors List of This Report Table 131. Secondary Sources Table 132. Primary Sources List of Figures Figure 1. Amino Acid Metabolism Disorder Drug Product Image Figure 2. Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Amino Acid Metabolism Disorder Drug Market Share by Type: 2025 VS 2032 Figure 4. Folic Acid Image Figure 5. Sapropterin Dihydrochloride Image Figure 6. Vitamin D Image Figure 7. Vitamin B6 & B12 Image Figure 8. Betaine Image Figure 9. Thiamine Image Figure 10. Carglumic Acid Image Figure 11. Arginine Image Figure 12. Others Image Figure 13. Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Amino Acid Metabolism Disorder Drug Market Share by Application: 2025 VS 2032 Figure 15. Argininosuccinic Acidemia Image Figure 16. Citrullinemia Image Figure 17. Homocystinuria Image Figure 18. Maple Syrup Urine Disease Image Figure 19. Phenylketonuria Image Figure 20. Global Amino Acid Metabolism Disorder Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 21. Global Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 22. Global Amino Acid Metabolism Disorder Drug Market Share by Region: 2025 VS 2032 Figure 23. Years Considered Figure 24. Global Amino Acid Metabolism Disorder Drug Market Share by Players in 2025 Figure 25. Global Top 5 and 10 Amino Acid Metabolism Disorder Drug Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Amino Acid Metabolism Disorder Drug Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Type (2021-2032) Figure 29. Global Amino Acid Metabolism Disorder Drug Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Amino Acid Metabolism Disorder Drug Revenue Market Share by Application (2021-2032) Figure 31. North America Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 32. North America Amino Acid Metabolism Disorder Drug Market Share by Type (2021-2032) Figure 33. North America Amino Acid Metabolism Disorder Drug Market Share by Application (2021-2032) Figure 34. North America Amino Acid Metabolism Disorder Drug Market Share by Country (2021-2032) Figure 35. United States Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 36. Canada Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 37. Mexico Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 38. Europe Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 39. Europe Amino Acid Metabolism Disorder Drug Market Share by Type (2021-2032) Figure 40. Europe Amino Acid Metabolism Disorder Drug Market Share by Application (2021-2032) Figure 41. Europe Amino Acid Metabolism Disorder Drug Market Share by Country (2021-2032) Figure 42. Germany Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 43. France Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 44. U.K. Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 45. Italy Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 46. Russia Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 47. Nordic Countries Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 48. China Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 49. China Amino Acid Metabolism Disorder Drug Market Share by Type (2021-2032) Figure 50. China Amino Acid Metabolism Disorder Drug Market Share by Application (2021-2032) Figure 51. Asia Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 52. Asia Amino Acid Metabolism Disorder Drug Market Share by Type (2021-2032) Figure 53. Asia Amino Acid Metabolism Disorder Drug Market Share by Application (2021-2032) Figure 54. Asia Amino Acid Metabolism Disorder Drug Market Share by Country (2021-2032) Figure 55. Japan Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 56. South Korea Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 57. Taiwan Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 58. Southeast Asia Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 59. India Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 60. Australia Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 61. South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 62. South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Share by Type (2021-2032) Figure 63. South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Share by Application (2021-2032) Figure 64. South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Share by Country (2021-2032) Figure 65. Brazil Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 66. South Africa Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 67. Saudi Arabia Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 68. Turkey Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 69. Argentina Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 70. UAE Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 71. Egypt Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 72. Chile Amino Acid Metabolism Disorder Drug Market Size (2021-2032) & (US$ Million) Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Folic Acid
  • Sapropterin Dihydrochloride
  • Vitamin D
  • Vitamin B6 & B12
  • Betaine
  • Thiamine
  • Carglumic Acid
  • Arginine
  • Others
Applications
  • Argininosuccinic Acidemia
  • Citrullinemia
  • Homocystinuria
  • Maple Syrup Urine Disease
  • Phenylketonuria
Companies covered
  • AMINO
  • BioMarin
  • DSM
  • Kyowa Hakko Kirin
  • Recordati
  • Shine Star (Hubei) Biological Engineering
  • Swedish Orphan Biovitrum
  • GlaxoSmithKline
  • Pfizer
  • Merck
  • Sanofi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Folic Acid
  5. 1.2.3 Sapropterin Dihydrochloride
  6. 1.2.4 Vitamin D
  7. 1.2.5 Vitamin B6 & B12
  8. 1.2.6 Betaine
  9. 1.2.7 Thiamine
  10. 1.2.8 Carglumic Acid
  11. 1.2.9 Arginine
  12. 1.2.10 Others
  13. 1.3 Market Analysis by Application
  14. 1.3.1 Global Amino Acid Metabolism Disorder Drug Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  15. 1.3.2 Argininosuccinic Acidemia
  16. 1.3.3 Citrullinemia
  17. 1.3.4 Homocystinuria
  18. 1.3.5 Maple Syrup Urine Disease
  19. 1.3.6 Phenylketonuria
  20. 1.4 Global Market Growth Prospects
  21. 1.5 Global Amino Acid Metabolism Disorder Drug Growth Trends by Region
  22. 1.5.1 Global Amino Acid Metabolism Disorder Drug Market Size by Region: 2021 VS 2025 VS 2032
  23. 1.5.2 Amino Acid Metabolism Disorder Drug Market Size by Region (2021-2026)
  24. 1.5.3 Amino Acid Metabolism Disorder Drug Market Size by Region (2027-2032)
  25. 1.6 Assumptions and Limitations
  26. 1.7 Study Goals and Objectives
  27. 1.8 Years Considered
2 Global Amino Acid Metabolism Disorder Drug Market Dynamics
  1. 2.1 Amino Acid Metabolism Disorder Drug Industry Trends
  2. 2.2 Amino Acid Metabolism Disorder Drug Industry Drivers
  3. 2.3 Amino Acid Metabolism Disorder Drug Industry Opportunities and Challenges
  4. 2.4 Amino Acid Metabolism Disorder Drug Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Amino Acid Metabolism Disorder Drug Revenue by Company (2021-2026)
  2. 3.2 Global Amino Acid Metabolism Disorder Drug Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Amino Acid Metabolism Disorder Drug Key Company Head office and Area Served
  4. 3.4 Global Amino Acid Metabolism Disorder Drug Company, Product Type & Application
  5. 3.5 Global Amino Acid Metabolism Disorder Drug Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Amino Acid Metabolism Disorder Drug Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Amino Acid Metabolism Disorder Drug Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Amino Acid Metabolism Disorder Drug Tier 1, Tier 2, and Tier 3
4 Amino Acid Metabolism Disorder Drug Market by Type
  1. 4.1 Global Amino Acid Metabolism Disorder Drug Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Amino Acid Metabolism Disorder Drug Market Size by Type (2021-2032)
  3. 4.3 Global Amino Acid Metabolism Disorder Drug Market Size Share by Type (2021-2032)
5 Amino Acid Metabolism Disorder Drug Market by Application
  1. 5.1 Global Amino Acid Metabolism Disorder Drug Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Amino Acid Metabolism Disorder Drug Market Size by Application (2021-2032)
  3. 5.3 Global Amino Acid Metabolism Disorder Drug Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 AMINO
  2. 6.1.1 AMINO Company Information
  3. 6.1.2 AMINO Business Overview
  4. 6.1.3 AMINO Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 AMINO Amino Acid Metabolism Disorder Drug Product Portfolio
  6. 6.1.5 AMINO Recent Developments
  7. 6.2 BioMarin
  8. 6.2.1 BioMarin Company Information
  9. 6.2.2 BioMarin Business Overview
  10. 6.2.3 BioMarin Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 BioMarin Amino Acid Metabolism Disorder Drug Product Portfolio
  12. 6.2.5 BioMarin Recent Developments
  13. 6.3 DSM
  14. 6.3.1 DSM Company Information
  15. 6.3.2 DSM Business Overview
  16. 6.3.3 DSM Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 DSM Amino Acid Metabolism Disorder Drug Product Portfolio
  18. 6.3.5 DSM Recent Developments
  19. 6.4 Kyowa Hakko Kirin
  20. 6.4.1 Kyowa Hakko Kirin Company Information
  21. 6.4.2 Kyowa Hakko Kirin Business Overview
  22. 6.4.3 Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Kyowa Hakko Kirin Amino Acid Metabolism Disorder Drug Product Portfolio
  24. 6.4.5 Kyowa Hakko Kirin Recent Developments
  25. 6.5 Recordati
  26. 6.5.1 Recordati Company Information
  27. 6.5.2 Recordati Business Overview
  28. 6.5.3 Recordati Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Recordati Amino Acid Metabolism Disorder Drug Product Portfolio
  30. 6.5.5 Recordati Recent Developments
  31. 6.6 Shine Star (Hubei) Biological Engineering
  32. 6.6.1 Shine Star (Hubei) Biological Engineering Company Information
  33. 6.6.2 Shine Star (Hubei) Biological Engineering Business Overview
  34. 6.6.3 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Shine Star (Hubei) Biological Engineering Amino Acid Metabolism Disorder Drug Product Portfolio
  36. 6.6.5 Shine Star (Hubei) Biological Engineering Recent Developments
  37. 6.7 Swedish Orphan Biovitrum
  38. 6.7.1 Swedish Orphan Biovitrum Company Information
  39. 6.7.2 Swedish Orphan Biovitrum Business Overview
  40. 6.7.3 Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Swedish Orphan Biovitrum Amino Acid Metabolism Disorder Drug Product Portfolio
  42. 6.7.5 Swedish Orphan Biovitrum Recent Developments
  43. 6.8 GlaxoSmithKline
  44. 6.8.1 GlaxoSmithKline Company Information
  45. 6.8.2 GlaxoSmithKline Business Overview
  46. 6.8.3 GlaxoSmithKline Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 GlaxoSmithKline Amino Acid Metabolism Disorder Drug Product Portfolio
  48. 6.8.5 GlaxoSmithKline Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Pfizer Amino Acid Metabolism Disorder Drug Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 Merck
  56. 6.10.1 Merck Company Information
  57. 6.10.2 Merck Business Overview
  58. 6.10.3 Merck Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Merck Amino Acid Metabolism Disorder Drug Product Portfolio
  60. 6.10.5 Merck Recent Developments
  61. 6.11 Sanofi
  62. 6.11.1 Sanofi Company Information
  63. 6.11.2 Sanofi Business Overview
  64. 6.11.3 Sanofi Amino Acid Metabolism Disorder Drug Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Sanofi Amino Acid Metabolism Disorder Drug Product Portfolio
  66. 6.11.5 Sanofi Recent Developments
7 North America
  1. 7.1 North America Amino Acid Metabolism Disorder Drug Market Size (2021-2032)
  2. 7.2 North America Amino Acid Metabolism Disorder Drug Market Size by Type
  3. 7.2.1 North America Amino Acid Metabolism Disorder Drug Market Size by Type (2021-2026)
  4. 7.2.2 North America Amino Acid Metabolism Disorder Drug Market Size by Type (2027-2032)
  5. 7.2.3 North America Amino Acid Metabolism Disorder Drug Market Share by Type (2021-2032)
  6. 7.3 North America Amino Acid Metabolism Disorder Drug Market Size by Application
  7. 7.3.1 North America Amino Acid Metabolism Disorder Drug Market Size by Application (2021-2026)
  8. 7.3.2 North America Amino Acid Metabolism Disorder Drug Market Size by Application (2027-2032)
  9. 7.3.3 North America Amino Acid Metabolism Disorder Drug Market Share by Application (2021-2032)
  10. 7.4 North America Amino Acid Metabolism Disorder Drug Market Size by Country
  11. 7.4.1 North America Amino Acid Metabolism Disorder Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Amino Acid Metabolism Disorder Drug Market Size by Country (2021-2026)
  13. 7.4.3 North America Amino Acid Metabolism Disorder Drug Market Size by Country (2027-2032)
  14. 7.4.4 North America Amino Acid Metabolism Disorder Drug Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Amino Acid Metabolism Disorder Drug Market Size (2021-2032)
  2. 8.2 Europe Amino Acid Metabolism Disorder Drug Market Size by Type
  3. 8.2.1 Europe Amino Acid Metabolism Disorder Drug Market Size by Type (2021-2026)
  4. 8.2.2 Europe Amino Acid Metabolism Disorder Drug Market Size by Type (2027-2032)
  5. 8.2.3 Europe Amino Acid Metabolism Disorder Drug Market Share by Type (2021-2032)
  6. 8.3 Europe Amino Acid Metabolism Disorder Drug Market Size by Application
  7. 8.3.1 Europe Amino Acid Metabolism Disorder Drug Market Size by Application (2021-2026)
  8. 8.3.2 Europe Amino Acid Metabolism Disorder Drug Market Size by Application (2027-2032)
  9. 8.3.3 Europe Amino Acid Metabolism Disorder Drug Market Share by Application (2021-2032)
  10. 8.4 Europe Amino Acid Metabolism Disorder Drug Market Size by Country
  11. 8.4.1 Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2021-2026)
  13. 8.4.3 Europe Amino Acid Metabolism Disorder Drug Market Size by Country (2027-2032)
  14. 8.4.4 Europe Amino Acid Metabolism Disorder Drug Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Amino Acid Metabolism Disorder Drug Market Size (2021-2032)
  2. 9.2 China Amino Acid Metabolism Disorder Drug Market Size by Type
  3. 9.2.1 China Amino Acid Metabolism Disorder Drug Market Size by Type (2021-2026)
  4. 9.2.2 China Amino Acid Metabolism Disorder Drug Market Size by Type (2027-2032)
  5. 9.2.3 China Amino Acid Metabolism Disorder Drug Market Share by Type (2021-2032)
  6. 9.3 China Amino Acid Metabolism Disorder Drug Market Size by Application
  7. 9.3.1 China Amino Acid Metabolism Disorder Drug Market Size by Application (2021-2026)
  8. 9.3.2 China Amino Acid Metabolism Disorder Drug Market Size by Application (2027-2032)
  9. 9.3.3 China Amino Acid Metabolism Disorder Drug Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Amino Acid Metabolism Disorder Drug Market Size (2021-2032)
  2. 10.2 Asia Amino Acid Metabolism Disorder Drug Market Size by Type
  3. 10.2.1 Asia Amino Acid Metabolism Disorder Drug Market Size by Type (2021-2026)
  4. 10.2.2 Asia Amino Acid Metabolism Disorder Drug Market Size by Type (2027-2032)
  5. 10.2.3 Asia Amino Acid Metabolism Disorder Drug Market Share by Type (2021-2032)
  6. 10.3 Asia Amino Acid Metabolism Disorder Drug Market Size by Application
  7. 10.3.1 Asia Amino Acid Metabolism Disorder Drug Market Size by Application (2021-2026)
  8. 10.3.2 Asia Amino Acid Metabolism Disorder Drug Market Size by Application (2027-2032)
  9. 10.3.3 Asia Amino Acid Metabolism Disorder Drug Market Share by Application (2021-2032)
  10. 10.4 Asia Amino Acid Metabolism Disorder Drug Market Size by Country
  11. 10.4.1 Asia Amino Acid Metabolism Disorder Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Amino Acid Metabolism Disorder Drug Market Size by Country (2021-2026)
  13. 10.4.3 Asia Amino Acid Metabolism Disorder Drug Market Size by Country (2027-2032)
  14. 10.4.4 Asia Amino Acid Metabolism Disorder Drug Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Amino Acid Metabolism Disorder Drug Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst